These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
209 related articles for article (PubMed ID: 31325518)
1. Sleep architecture changes in the APP23 mouse model manifest at onset of cognitive deficits. Van Erum J; Van Dam D; Sheorajpanday R; De Deyn PP Behav Brain Res; 2019 Nov; 373():112089. PubMed ID: 31325518 [TBL] [Abstract][Full Text] [Related]
2. Age-dependent cognitive decline in the APP23 model precedes amyloid deposition. Van Dam D; D'Hooge R; Staufenbiel M; Van Ginneken C; Van Meir F; De Deyn PP Eur J Neurosci; 2003 Jan; 17(2):388-96. PubMed ID: 12542676 [TBL] [Abstract][Full Text] [Related]
3. Sleep-Wake Cycle Dysfunction in the TgCRND8 Mouse Model of Alzheimer's Disease: From Early to Advanced Pathological Stages. Colby-Milley J; Cavanagh C; Jego S; Breitner JC; Quirion R; Adamantidis A PLoS One; 2015; 10(6):e0130177. PubMed ID: 26076358 [TBL] [Abstract][Full Text] [Related]
4. Cannabinoid receptor 1 deficiency in a mouse model of Alzheimer's disease leads to enhanced cognitive impairment despite of a reduction in amyloid deposition. Stumm C; Hiebel C; Hanstein R; Purrio M; Nagel H; Conrad A; Lutz B; Behl C; Clement AB Neurobiol Aging; 2013 Nov; 34(11):2574-84. PubMed ID: 23838176 [TBL] [Abstract][Full Text] [Related]
5. Intracerebral microinjection of interleukin-4/interleukin-13 reduces β-amyloid accumulation in the ipsilateral side and improves cognitive deficits in young amyloid precursor protein 23 mice. Kawahara K; Suenobu M; Yoshida A; Koga K; Hyodo A; Ohtsuka H; Kuniyasu A; Tamamaki N; Sugimoto Y; Nakayama H Neuroscience; 2012 Apr; 207():243-60. PubMed ID: 22342341 [TBL] [Abstract][Full Text] [Related]
6. Environmental enrichment lessens cognitive decline in APP23 mice without affecting brain sirtuin expression. Polito L; Chierchia A; Tunesi M; Bouybayoune I; Kehoe PG; Albani D; Forloni G J Alzheimers Dis; 2014; 42(3):851-64. PubMed ID: 24961946 [TBL] [Abstract][Full Text] [Related]
7. Comparative studies using the Morris water maze to assess spatial memory deficits in two transgenic mouse models of Alzheimer's disease. Edwards SR; Hamlin AS; Marks N; Coulson EJ; Smith MT Clin Exp Pharmacol Physiol; 2014 Oct; 41(10):798-806. PubMed ID: 25115283 [TBL] [Abstract][Full Text] [Related]
8. Cerebral inoculation of human A53T α-synuclein reduces spatial memory decline and amyloid-β aggregation in APP/PS1 transgenic mice of Alzheimer's disease. Hao YN; Lu QX; Zhai YH; Wang HY; Wu MN; Hu MM; Yang B; Wang ZJ; Wu ZW; Qi JS Brain Res Bull; 2018 Oct; 143():116-122. PubMed ID: 30366065 [TBL] [Abstract][Full Text] [Related]
9. Traumatic Brain Injury by Weight-Drop Method Causes Transient Amyloid- Shishido H; Ueno M; Sato K; Matsumura M; Toyota Y; Kirino Y; Tamiya T; Kawai N; Kishimoto Y Behav Neurol; 2019; 2019():3248519. PubMed ID: 30944661 [TBL] [Abstract][Full Text] [Related]
10. Behavioral and psychological symptoms of dementia (BPSD) and impaired cognition reflect unsuccessful neuronal compensation in the pre-plaque stage and serve as early markers for Alzheimer's disease in the APP23 mouse model. Pfeffer A; Munder T; Schreyer S; Klein C; Rasińska J; Winter Y; Steiner B Behav Brain Res; 2018 Jul; 347():300-313. PubMed ID: 29572105 [TBL] [Abstract][Full Text] [Related]
11. Reduction in open field activity in the absence of memory deficits in the App Whyte LS; Hemsley KM; Lau AA; Hassiotis S; Saito T; Saido TC; Hopwood JJ; Sargeant TJ Behav Brain Res; 2018 Jan; 336():177-181. PubMed ID: 28887197 [TBL] [Abstract][Full Text] [Related]
12. EEG, activity, and sleep architecture in a transgenic AβPPswe/PSEN1A246E Alzheimer's disease mouse. Jyoti A; Plano A; Riedel G; Platt B J Alzheimers Dis; 2010; 22(3):873-87. PubMed ID: 20858963 [TBL] [Abstract][Full Text] [Related]
13. Amyloid precursor protein mutation disrupts reproductive experience-enhanced normal cognitive development in a mouse model of Alzheimer's disease. Cui J; Jothishankar B; He P; Staufenbiel M; Shen Y; Li R Mol Neurobiol; 2014 Feb; 49(1):103-12. PubMed ID: 23853041 [TBL] [Abstract][Full Text] [Related]
14. Overexpression of Ubiquilin-1 Alleviates Alzheimer's Disease-Caused Cognitive and Motor Deficits and Reduces Amyloid-β Accumulation in Mice. Adegoke OO; Qiao F; Liu Y; Longley K; Feng S; Wang H J Alzheimers Dis; 2017; 59(2):575-590. PubMed ID: 28598849 [TBL] [Abstract][Full Text] [Related]
15. Enriched endogenous n-3 polyunsaturated fatty acids alleviate cognitive and behavioral deficits in a mice model of Alzheimer's disease. Wu K; Gao X; Shi B; Chen S; Zhou X; Li Z; Gan Y; Cui L; Kang JX; Li W; Huang R Neuroscience; 2016 Oct; 333():345-55. PubMed ID: 27474225 [TBL] [Abstract][Full Text] [Related]
16. Sleep and EEG Power Spectral Analysis in Three Transgenic Mouse Models of Alzheimer's Disease: APP/PS1, 3xTgAD, and Tg2576. Kent BA; Strittmatter SM; Nygaard HB J Alzheimers Dis; 2018; 64(4):1325-1336. PubMed ID: 29991134 [TBL] [Abstract][Full Text] [Related]
17. Amyloid β Protein Aggravates Neuronal Senescence and Cognitive Deficits in 5XFAD Mouse Model of Alzheimer's Disease. Wei Z; Chen XC; Song Y; Pan XD; Dai XM; Zhang J; Cui XL; Wu XL; Zhu YG Chin Med J (Engl); 2016 Aug; 129(15):1835-44. PubMed ID: 27453234 [TBL] [Abstract][Full Text] [Related]
18. Age and sex differences in motivation and spatial working memory in 3xTg-AD mice in the Hebb-Williams maze. Fertan E; Wong AA; Vienneau NA; Brown RE Behav Brain Res; 2019 Sep; 370():111937. PubMed ID: 31121220 [TBL] [Abstract][Full Text] [Related]
19. Soluble Aβ levels correlate with cognitive deficits in the 12-month-old APPswe/PS1dE9 mouse model of Alzheimer's disease. Zhang W; Hao J; Liu R; Zhang Z; Lei G; Su C; Miao J; Li Z Behav Brain Res; 2011 Sep; 222(2):342-50. PubMed ID: 21513747 [TBL] [Abstract][Full Text] [Related]
20. High-fat diet exacerbates cognitive decline in mouse models of Alzheimer's disease and mixed dementia in a sex-dependent manner. Gannon OJ; Robison LS; Salinero AE; Abi-Ghanem C; Mansour FM; Kelly RD; Tyagi A; Brawley RR; Ogg JD; Zuloaga KL J Neuroinflammation; 2022 May; 19(1):110. PubMed ID: 35568928 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]